Health ❯Medications ❯Weight Loss Drugs ❯GLP-1 Agonists

Semaglutide

Ozempic Shows Potential to Reduce Alcohol Consumption in Clinical Trial

Novo Nordisk to Investigate Ozempic's Impact on Alcohol Consumption